Previous close | 2.2000 |
Open | N/A |
Bid | 0.1000 |
Ask | 3.0000 |
Strike | 5.00 |
Expiry date | 2024-09-20 |
Day's range | 2.2000 - 2.2000 |
Contract range | N/A |
Volume | |
Open interest | N/A |
Accuray (ARAY) announces the approval of the Accuray Precision Treatment Planning System by the Chinese Medical Products Administration.
Accuray Incorporated (NASDAQ: ARAY) announced today that the registration dossier for the Accuray Precision® Treatment Planning System (TPS) has been approved by the Chinese National Medical Products Administration (NMPA). The Accuray Precision TPS is now available for use with the CNNC-Accuray joint venture Tomo® C radiation therapy system and in combination, will provide medical care teams with a new option for delivering extremely precise and accurate radiotherapy treatments, ultimately expan
Inogen (INGN) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.